普洛药业：累计回购公司股份10030000股

Core Viewpoint - Pro Pharmaceutical announced the repurchase of 10,030,000 shares, representing 0.87% of its total share capital of 1,158,443,576 shares, as of July 31, 2025 [2] Summary by Category - Company Actions - The company has initiated a share repurchase program, acquiring a total of 10,030,000 shares through a dedicated repurchase account via centralized bidding [2] - Share Capital Information - The repurchased shares account for 0.87% of the company's total share capital, which stands at 1,158,443,576 shares [2]